Fermion Technology partners with Simcere Pharmaceutical to develop and commercialise FZ002-037, a clinical-stage non-opioid ...

Numbers of ongoing advanced therapy clinical trials in the UK reached 187 in 2024, an increase of 7% compared to the previous ...

Novartis sues HHS over rejection of a proposed 340B rebate model, arguing it enhances transparency and compliance while ...

India’s Sun Pharmaceutical Industries announced that its subsidiary, Taro Pharmaceuticals, has entered into an agreement to ...

The European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for ...

In what it describes as a significant step forward for India’s cancer treatment, India’s cell and gene therapy start-up ...

Germany’s Formycon and its licensing partner Klinge Biopharma have announced that the European Commission (EC) has granted ...

Germany’s pharma sector tackles drug shortages with a VFA-led plan emphasising supply chain resilience, stock management, and ...

Japanese drugmaker Sumitomo Pharma Company has concluded a co-promotion collaboration partner agreement with US healthcare ...

There are good points in the Danish National Board of Health's professional presentation for Cancer Plan V, which was ...

Orexo converts royalty rights from vipoglanstat into Gesynta Pharma shares valued at 19.2M kroner, following Gesynta’s capital raise. Gesynta will fund a Phase II trial of vipoglanstat, a promising ...

ReciBioPharm, a division of Sweden-headquartered contract development and manufacturing organization (CDMO) Recipharm, has been awarded a three-year grant from the Bill & Melinda Gates Foundation ...